Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Halozyme Therapeutics
(HTI) Q3 2025
Earnings
HTI
Aug 5
Confirmed
Q1 2025
Q2 2025
Q3 2025
0.96
1.15
1.35
1.54
Details
Expected EPS
1.268333
Actual EPS
1.54
Surprise EPS
0.27
Surprise Percent
+21.42%
Description
Halozyme Therapeutics (HTI) has reported earnings of 1.54 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login